A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Hematologic Malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511457-22-00

Acronym

KQB198-102

Enrollment

Registered

2025-01-15

Start date

2025-01-30

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Hematologic Malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Netherlands, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026